ZANOSAR- streptozocin powder, for solution

Zanosar by

Drug Labeling and Warnings

Zanosar by is a Prescription medication manufactured, distributed, or labeled by ESTEVE PHARMACEUTICALS, S.A.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

HEALTH CARE PROVIDER LETTER

Dear Health Care Provider Letter

HOW SUPPLIED

How supplied

NDC: 68118-100-01: Each vial contains 1g Streptozocin Powder for concentrate for solution for infusion. Each carton contains 1 vial.

PRINCIPAL DISPLAY PANEL

Vial Label

PRINCIPAL DISPLAY PANEL

Carton Label

INGREDIENTS AND APPEARANCE

ZANOSAR 
streptozocin powder, for solution

Product Information
Product Type	HUMAN PRESCRIPTION DRUG	Item Code (Source)	NDC: 68118-100
Route of Administration	INTRAVENOUS

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
STREPTOZOCIN (UNII: 5W494URQ81) (STREPTOZOCIN - UNII:5W494URQ81)	STREPTOZOCIN	1 g  in 10 mL

Inactive Ingredients
Ingredient Name	Strength
ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)
SODIUM HYDROXIDE (UNII: 55X04QC32I)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 68118-100-01	1 in 1 CARTON	02/01/2023
1		10 mL in 1 VIAL, GLASS; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Unapproved drug for use in drug shortage		02/01/2023

Labeler - ESTEVE PHARMACEUTICALS, S.A. (460023922)